2741 - 2750 of 8684 Results
Title
Year
-
OPENTitle: Future of cell and gene therapies for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 64Issue #: S2Start Page: S122End Page: S138Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.21473Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3982797Citation Count: 53
-
OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Citation Count: 26
-
OPENTitle: Non-radioactive in vitro PINK1 Kinase Assays Using Ubiquitin or Parkin as SubstrateJournal Name: BIO-PROTOCOLPublisher: Bio-Protocol, LLCVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.21769/bioprotoc.1946Best OA location URL: https://europepmc.org/articles/pmc5448420?pdf=renderCitation Count: 6
-
OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 32
-
RESTRICTEDTitle: Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromesJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 4Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12940Citation Count: 10
-
OPENTitle: Hypercholinergic activity in LRRK2 Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 290End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30073-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5858987Citation Count: 6
- Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid‐Onset Dystonia‐Parkinsonism (DYT12)2017OPENTitle: Failure of Sequential Pallidal and Motor Thalamus DBS for Rapid‐Onset Dystonia‐Parkinsonism (DYT12)Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 444End Page: 445Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12559Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12559Citation Count: 11
-
OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 55
-
OPENTitle: Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathologyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 54Issue #:Start Page: 175End Page: 186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5862548Citation Count: 31
-
OPENTitle: A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrierJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 405End Page: 409Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26450Citation Count: 18